SAGE-547 Injection

· Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAGE-547 Injection, covering 2022-05-03 to 2022-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus [Phase 1, Phase 2]

See pricing